Work

Phase I study combining PARP-inhibition with immune checkpoint blockade in women with BRCA-deficient recurrent ovarian cancer

Year: 2017

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2017.03.234

Authors: S.F. Adams, O. Rixe, D. McCance, J.H. Lee, S. Eberhardt, S. Westgate, T. Rutledge, C. Muller

Institutions: University of New Mexico, UNM Comprehensive Cancer Center

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2624476544

FWCI: 0.325

Cites:

Cited by: 4

Related to: 10